Product image of Lindynette 20 (Ethinylestradiol, Gestodene) supplied by GNH India

Lindynette 20

Active Ingredient:
Ethinylestradiol, Gestodene
Origin:
EU

Lindynette 20 (Ethinylestradiol, Gestodene)

Ethinylestradiol, the active ingredient in Lindynette 20, is a combined oral contraceptive presented as a 20 µg/0.075 mg oral tablet for oral use. Together with gestodene, it works to prevent pregnancy in women of reproductive age by inhibiting ovulation and altering cervical mucus.\n\nGNH India supplies Lindynette 20 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product meets EU regulatory standards and is manufactured under strict quality controls.

Manufacturer / TM Owner

Gedeon Richter Plc.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Lindynette 20, a combined oral contraceptive, is indicated for hormonal contraception in women.\n\nContraception (prevention of pregnancy): reliable reversible prevention of pregnancy when taken as directed.\nDysmenorrhea: reduction of menstrual pain through hormonal stabilization.\nMenstrual cycle regulation: helps achieve more predictable bleeding patterns.

How It Works

  • Ethinylestradiol and gestodene bind to estrogen and progestogen receptors, respectively, suppressing the hypothalamic‑pituitary‑ovarian axis. This inhibition reduces luteinizing hormone (LH) and follicle‑stimulating hormone (FSH) release, preventing follicular development and ovulation. The progestogenic component also thickens cervical mucus and induces endometrial changes that impede fertilisation and implantation.

Side Effects

  • Lindynette 20 may cause a range of adverse reactions.\n\nCommon Side Effects:\n- Nausea: mild to moderate stomach upset.\n- Breast tenderness: temporary swelling or soreness.\n- Headache: occasional mild to moderate pain.\n- Spotting or breakthrough bleeding: irregular light bleeding between periods.\n- Weight gain: modest increase in body weight.\n- Mood changes: irritability or mood swings.\n\nSerious or Rare Side Effects:\n- Venous thromboembolism: deep‑vein clot formation.\n- Arterial thrombosis: stroke or myocardial infarction risk.\n- Severe hypertension: sudden high blood pressure.\n- Liver disorders: cholestatic jaundice or hepatic adenoma.\n- Anaphylaxis: life‑threatening allergic reaction.

Precautions & Warnings

  • Before prescribing Lindynette 20, clinicians should evaluate individual risk factors and counsel patients on safe use.\n\nMedical review: assess thromboembolic risk, cardiovascular disease, and liver function.\nSmoking: avoid use in women over 35 who smoke.\nDrug interactions: review concomitant medications that may affect efficacy.\nPregnancy: discontinue immediately if pregnancy is confirmed.\nBreastfeeding: discuss potential risks with a healthcare provider.\nStore at ambient temperature: keep below 25 °C, retain in original packaging, and protect from moisture.

Avoid Interactions

  • Lindynette 20 can interact with several medicines, altering its effectiveness or safety profile.\n\nMajor Interactions (Avoid):\n- Strong CYP3A4 inducers (e.g., rifampicin, carbamazepine, phenytoin): may markedly reduce contraceptive efficacy.\n- Anticoagulants (e.g., warfarin): hormonal changes can affect clotting parameters.\n\nModerate Interactions (Monitor Closely):\n- Antifungals (e.g., ketoconazole, itraconazole): may increase hormone levels, raising side‑effect risk.\n- Selective serotonin reuptake inhibitors (SSRIs): can alter bleeding patterns.\n- Herbal supplements (e.g., St. John’s wort): may diminish contraceptive effectiveness.

Frequently Asked Questions

Lindynette 20 is a combined oral contraceptive indicated for the prevention of pregnancy in women of reproductive age. It may also be prescribed to manage dysmenorrhea and to help regulate menstrual cycles when used under medical supervision.

Ethinylestradiol, together with gestodene, suppresses the hypothalamic‑pituitary‑ovarian axis, inhibiting the release of luteinising hormone (LH) and follicle‑stimulating hormone (FSH). This prevents ovulation, thickens cervical mucus, and alters the endometrium, creating conditions that block fertilisation and implantation.

The dosing regimen for Lindynette 20 is determined by the prescribing healthcare professional. Typically, the product is taken once daily as part of a cyclic regimen, but the exact schedule and duration should follow the prescriber’s instructions.

Lindynette 20 should not be used during pregnancy; it is discontinued if pregnancy is confirmed. While limited data exist for breastfeeding, the decision to use hormonal contraception while nursing should be made in consultation with a healthcare provider, weighing potential benefits and risks.

To order Lindynette 20, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lindynette 20 contains a low‑dose ethynylestradiol (20 µg) combined with gestodene, offering a balance of efficacy and tolerability. Compared with higher‑dose formulations, it may present a lower risk of estrogen‑related side effects while maintaining reliable contraceptive protection.

Lindynette 20 tablets should be stored at ambient temperature, below 25 °C, in their original blister pack. Keep the product away from moisture, direct sunlight, and excessive heat to maintain stability.

Lindynette 20 is taken orally, usually once each day at the same time, as part of a 21‑day active tablet sequence followed by a 7‑day pill‑free interval, unless a different regimen is prescribed by a healthcare professional.

Serious risks include venous thromboembolism, arterial thrombosis (such as stroke or myocardial infarction), severe hypertension, liver disorders, and rare allergic reactions. Patients should seek immediate medical attention if they experience symptoms like unexplained leg pain, chest pain, severe headache, or jaundice.

Women with a history of thromboembolic disease, uncontrolled hypertension, certain liver disorders, known or suspected breast cancer, or who are pregnant should avoid Lindynette 20. Smoking women over 35 years of age are also advised against its use.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ethinylestradiol, Gestodene

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT